Speakers - Neuroimmunology Drug Development Summit

Speakers

Andrew Pincetic

Director Neuro-immunology

Alector

Brian Hopkins

Director, Small Molecule Drug Design

Biogen

Bruno Cenni

Executive Director

Novartis

Courtney Easley-Neal

Director & Head of Translational Models Department

Eisai

David Gray

Chief Scientific Officer

Vigil Neuroscience

Delphine Fagegaltier

Senior Principal Scientist, Human Genetics, Neuroscience Lead

Merck

Dimitry Ofengeim

Dimitry Ofengeim

Head of Precision Neurology & Neuroinflammation Cluster

Sanofi

Eli Shobin

Senior Director & Head of Diagnostic Accelerator

Alzheimer’s Drug Discovery Foundation

Erica Koval

Principal Scientist & Research Program Lead

Biogen

Fabrizio Gasparini

Executive Director & Head of Neuroinflammation & Neuroscience Research

Novartis

Hella Kohlhof

Chief Scientific Officer

Immunic Therapeutics

Iosif (Sifis) Pediaditakis

Co-Founder & Vice President, Head of Biology

Phragma Therapeutics

James Keaney

Lab Head & Research Project Leader

Roche

Jean-Philippe Courade

Chief Scientific Officer

Discoveric Bio

Jeffrey Cleland

Chairman, President & Chief Executive Officer

Ashvattha Therapeutics

Juan Pablo de Rivero Vaccari

Associate Professor

University of Miami School of Medicine

Kelly Pike

Senior Director & Head of Translational Sciences & Disease Strategy

Ventus Therapeutics

Manuela Polydoro

Vice President, Head of Translational Medicine

Muna Therapeutics

Marianthi Papakosta

Director, Neuroscience Biology Research

Neurocrine Bioscience

Marla Weetall

Senior Vice President, Pharmacology and Biomarkers

PTC Bio

Mary Hamby

Vice President - Research

Cognition Therapeutics Inc

Michelle Sidor

Director of Neuroscience

Alchemab

Milos Kostic

Senior Scientist

Eisai Co., Ltd.

Nellwyn Hagan

Senior Principal Scientist & Lab Head

Sanofi

Olga Liaudanskaya

Assistant Professor, Biomedical Engineering

University of Cincinnati

Paul Ashton

President & Chief Executive Officer

Inflammasome Therapeutics

Richard Ransohoff

Co-Founder & Chief Medical Officer

Abata Therapeutics

Ross Gruber

Associate Director, External Neuroscience Innovation

Takeda Pharmaceutical

Sakura Minami

Vice President, Translational Medicine & Nonclinical Development

Ashvattha Therapeutics

Shreaya Chakroborty

Program Director

National Institute of Health Science

Stephanie McTighe

Senior Director Pharmacology

Delix Therapeutics

Thomas Tamsett

Director of Neuroscience

EMD Serono

Valentina Di Caro

Director, Research

Cognition Therapeutics

Vladimir Litvak

Director, Global Clinical & Translational Sciences

Takeda Pharmaceutical

Xavier Taylor

Advisor

Eli Lilly & Co.

PRE-CONFERENCE WORKSHOP DAY